Features | Partner Sites | Information | LinkXpress
Sign In
Advantech Europe

Antiparalytic Nasal Spray Treats Venomous Snakebites

By HospiMedica International staff writers
Posted on 19 Aug 2013
Topical administration of antiparalytics using a nasal spray could dramatically reduce the number of global fatalities from venomous snakebites.

Researchers at The California Academy of Sciences (CAS; San Francisco, USA) and the University of California, San Francisco (UCSF; USA) have developed an inexpensive, heat-stable, needle-free device that delivers aerosolized neostigmine to reverse paralysis. Since anticholinesterases are used as reversal agents for nondepolarizing curare-derived neuromuscular blocking agents, and are recommended in virtually all cases of neurotoxic snake envenomation, the researchers hypothesized that a topically applied anticholinesterase might also have utility in the early treatment of snakebite.

The researchers then used a continuous infusion of mivacurium—a short-duration nondepolarizing neuromuscular blocking agent—to induce neuromuscular blockade in a volunteer, successfully mimicking important elements of paralysis from snakebite neurotoxicity, including progressive bulbar deficits and neck and respiratory muscle weakness. A subsequent single application of atomized 6% neostigmine quickly improved the clinical measures of neuromuscular blockade. The study was published early online on July 24, 2013, in Clinical Case Reports.

“In addition to being an occupational hazard for field scientists, snakebite is a leading cause of accidental death in the developing world, especially among otherwise healthy young people,” said lead author Matt Lewin, PhD, director of the center for exploration and travel health at the CAS. “We are trying to change the way people think about this ancient scourge and persistent modern tragedy by developing an inexpensive, heat stable, easy-to-use treatment that will at least buy people enough time to get to the hospital for further treatment.”

Snakebite causes numerous fatalities, comparable to that of AIDS in some developing countries. Predominantly killing young and otherwise healthy individuals, the neurotoxins paralyze victims, resulting in death by respiratory failure. There is currently little funding to devise new approaches to address this problem, with more than 75% of patients who die from snakebite not surviving to receive treatment.

Related Links:

California Academy of Sciences
University of California, San Francisco

Asian Healthcare Show
Cincinnati Sub-Zero


Surgical Techniques

view channel
Image: The Cardioband direct annuloplasty system (Photo courtesy of Valtech Cardio).

Annuloplasty System Promotes Mitral Valve Repair

An implantable mitral reconstruction device proves a highly effective treatment option for reducing functional mitral regurgitation (MR). The Cardioband mitral reconstruction system combines a reconstruction... Read more

Women's Health

view channel

Pregnancy Complications Raise Heart Disease Risk

A new study suggests a high correlation between women who experienced complications during pregnancy and those facing death from heart disease later in life. Researchers at the Public Health Institute (PHI; Oakland, CA, USA; Berkeley, CA) conducted a study involving 14,062 women, examining pregnancy events over five... Read more

Patient Care

view channel
Image: The NIFTY cup (Photo courtesy of PATH).

NIFTY Cup Aids Infants Who Cannot Breastfeed

A novel cup has been designed to facilitate feeding and prevent starvation in infants in developing countries who are unable to breastfeed. The Neonatal Intuitive Feeding TechnologY (NIFTY) cup, developed... Read more

Hospital News

view channel

Universal Health Services to Acquire Foundations Recovery Network

Hospital operator Universal Health Services (UHS; King of Prussia, PA, USA) has entered an agreement to buy addiction treatment provider Foundations Recovery Network (FRN; Brentwood, TN, USA) for USD 350 million. Founded in 1995, FRN is a leader in addiction treatment and focused on treating adults with addiction and... Read more


view channel

Qualcomm Buys Connectivity Company Capsule Technologie

Qualcomm Life (San Diego, CA, USA) has purchased Capsule Technologie (Andover, MA, USA) in a bid to become one of the world's largest open connected health ecosystems. Financial details remain undisclosed. Qualcomm Life, a division of the 3G, 4G, and next-generation wireless technology conglomerate Qualcomm (San Diego,... Read more


08 Oct 2015 - 10 Oct 2015
08 Oct 2015 - 10 Oct 2015
08 Oct 2015 - 10 Oct 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.